About 908 Devices Inc
Ticker
info
MASS
Trading on
info
NASDAQ
ISIN
info
US65443P1021
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Dr. Kevin J. Knopp Ph.D.
Headquarters
info
645 Summer Street, Boston, MA, United States, 02210
Employees
info
246
Website
info
https://908devices.com
908 Devices Inc., a commercial-stage technology company. The company provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. It also provides include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Metrics
BasicAdvanced
Market cap
info
$150M
P/E ratio
info
-
EPS
info
-$2.12
Dividend Yield
info
0.00%
Beta
info
0.99
Forward P/E ratio
info
0
EBIDTA
info
$-43.9M
Ex dividend date
info
-
Price & volume
Market cap
info
$150M
Average daily volume
info
7.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
2.51
Price to book
info
1.31
Earnings
EPS
info
-$2.12
EPS estimate (current quarter)
info
-$0.35
EPS estimate (next quarter)
info
-$0.37
EBITDA
info
$-43.9M
Revenues (TTM)
info
$59.6M
Revenues per share (TTM)
info
$1.75
Technicals
Beta
info
0.99
52-week High
info
$7.56
52-week Low
info
$1.81
50-day moving average
info
$2.96
200-day moving average
info
$3.59
Short ratio
info
8.13
Short %
info
10.15%
Management effectiveness
ROE (TTM)
info
51.56%
ROA (TTM)
info
16.75%
Profit margin
info
121.09%
Gross profit margin
info
$29.9M
Operating margin
info
55.70%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
31.10%
Share stats
Outstanding Shares
info
35.3M
Float
info
21.8M
Insiders %
info
8.09%
Institutions %
info
63.48%
Analyst Insights & forecasts
info

80% Buy

20% Hold

0% Sell

Based on information from 5 analysts.

Average price target

info
$5.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.33
-$0.36
8.33%
Q1 • 24Beat
-$0.31
-$0.33
6.06%
Q2 • 24Beat
-$0.85
-$0.28
201.79%
Q3 • 24Beat
-$0.28
-$0.35
19.15%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$16.8M
$-29.3M
174.66%
Q3 • 24
$18.8M
$-19.4M
103.33%
Q4 • 24
12.20%
33.62%
40.84%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$178M
$47.2M
26.50%
Q3 • 24
$159M
$44.9M
28.14%
Q4 • 24
10.55%
5.00%
6.21%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-5.6M
$3.8M
$0M
$-5.8M
Q3 • 24
$-2.2M
$0.8M
$0.5M
$-2.4M
Q4 • 24
60.00%
79.42%
2,200.00%
57.78%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Greed

+1.5

0.33

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a 908 Devices Inc share?
Collapse

908 Devices Inc shares are currently traded for undefined per share.

How many shares does 908 Devices Inc have?
Collapse

908 Devices Inc currently has 35.3M shares.

Does 908 Devices Inc pay dividends?
Collapse

No, 908 Devices Inc doesn't pay dividends.

What is 908 Devices Inc 52 week high?
Collapse

908 Devices Inc 52 week high is $7.56.

What is 908 Devices Inc 52 week low?
Collapse

908 Devices Inc 52 week low is $1.81.

What is the 200-day moving average of 908 Devices Inc?
Collapse

908 Devices Inc 200-day moving average is $3.59.

Who is 908 Devices Inc CEO?
Collapse

The CEO of 908 Devices Inc is Dr. Kevin J. Knopp Ph.D..

How many employees 908 Devices Inc has?
Collapse

908 Devices Inc has 246 employees.

What is the market cap of 908 Devices Inc?
Collapse

The market cap of 908 Devices Inc is $150M.

What is the P/E of 908 Devices Inc?
Collapse

The current P/E of 908 Devices Inc is null.

What is the EPS of 908 Devices Inc?
Collapse

The EPS of 908 Devices Inc is -$2.12.

What is the PEG Ratio of 908 Devices Inc?
Collapse

The PEG Ratio of 908 Devices Inc is null.

What do analysts say about 908 Devices Inc?
Collapse

According to the analysts 908 Devices Inc is considered a buy.